Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

Average yearly return: +47%

Insulet posted revenues of $226.30 million for the quarter ended June 2020. This compares to year-ago revenues of $177.14 million.
Strong buy | |
Buy | |
X | Wait |
Sell | |
Strong sell |
If you found this site useful and want to help keep it alive,

to cover the costs and keep the site free of advertisements! Thank you for your support!